Narrative review of value frameworks in urothelial carcinoma and positioning of enfortumab vedotin
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimabnin Spain
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
